Which everyday drugs have been linked to dementia?
Taking medication for depression, Parkinson’s and incontinence may increase risk, study finds
Millions of people are taking routine medication that may significantly increase their risk of developing dementia later in life, scientists are warning.
Research has suggested that anticholinergic medications, prescribed to control muscle contractions or for mental health conditions, may cause mental declines later in life.
The drugs, used by as many as two million people in England alone, “are known to cause short-term confusion, and after previous studies suggested that they might lead to dementia, researchers set out to find stronger evidence”, says The Times.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The new study, published in the British Medical Journal, looked at the risk of new-onset dementia among almost 325,000 older adults in the UK.
“We found that people who had been diagnosed with dementia were up to 30% more likely to have been prescribed specific classes of anticholinergic medications,” said lead study author Dr George Savva, from the University of East Anglia’s School of Health Sciences.
Antihistamines and other less potent anticholinergics used for travel sickness or stomach cramps were not linked to dementia, the report said.
However, the risk does appear to increase with long-term use of stronger drugs. “The biggest effect was in drugs used for bladder disorders; such as oxybutynin and tolterodine; antidepressants, including amitriptyline and paroxetine; and Parkinson’s disease, including benzatropine and procyclidine,” says The Independent.
Dr Savva and his team say that everyone’s risks will be different, depending on the medicine, their genetic make-up and their lifestyle.
As a general rule, they say, someone with a 10% of developing dementia in the next 15 years would see that increase to 13% if they had been on anticholinergics for a year or more - or a “one in 33 chance of getting dementia you would otherwise not have got”.
Experts emphasise that patients should not stop taking the drugs, as their benefits may outweigh any risk.
Ian Maidment, of Aston University, who co-authored the study, told the BBC: “Don't do anything suddenly. Don’t stop taking your medication.”
The number of older people taking five or more medicines has quadrupled in the past two decades, fuelling the need for more research into the effects of taking a “cocktail” of prescribed drugs, Maidment said.
The focus now should be on “de-prescribing”, he insisted, adding: “Doctors, nurses and pharmacists need to work with older people and their carers to ensure that they take medication only if the benefits clearly outweigh the harms.”
Dr James Prickett, head of research at the Alzheimer’s Society, echoed that advice. He told the BBC that compared with the risk posed by leading an unhealthy lifestyle, the potential risk of an anticholinergic drug contributing to the onset of the disease was “quite small”.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
'A direct, protracted war with Israel is not something Iran is equipped to fight'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
Today's political cartoons - April 17, 2024
Cartoons Wednesday's cartoons - political anxiety, jury sorting hat, and more
By The Week US Published
-
Arid Gulf states hit with year's worth of rain
Speed Read The historic flooding in Dubai is tied to climate change
By Peter Weber, The Week US Published
-
Narcan is becoming harder to find at drugstores across America
Under the Radar The drug, also known as naloxone, reverses the effects of an opioid overdose
By Justin Klawans, The Week US Published
-
The lows of an unregulated high: Teens are using marijuana alternative delta-8
In the Spotlight More than 1 in 10 high school seniors have reported using the substance, which contains concentrated THC
By Justin Klawans, The Week US Published
-
How the transmission of Alzheimer's might be possible
The Explainer New research links dementia cases to injections of human growth hormone from deceased donors' brains
By Chas Newkey-Burden, The Week UK Published
-
Tianeptine: why lawmakers fear a new kind of opioid
The explainer The drug is sold over the counter. And is highly addictive.
By Devika Rao, The Week US Published
-
The pros and cons of compounding pharmacies
Pros and cons Customizing medications can be lifesaving and also dangerous
By Devika Rao, The Week US Published
-
How polysubstance abuse is worsening the American opioid crisis
The Explainer Studies are showing that more Americans are struggling with dependency on multiple substances.
By Theara Coleman, The Week US Published
-
Kush: the drug destroying young lives in West Africa
The Explainer There has been a sharp rise in young addicts in Sierra Leone, Guinea and Liberia
By Flora Neville, The Week UK Published
-
Magic mushrooms and the mind
The Explainer A growing number of states and cities are legalizing the use of psychedelic fungi in therapy. Some experts think that’s a big risk.
By The Week US Published